Page 1114 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 1114
980.e4 Part VII Hematologic Malignancies
NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells. 115. Campoli M, Ferrone S: HLA antigen changes in malignant cells:
Leuk Res 34:899, 2010. epigenetic mechanisms and biologic significance. Oncogene 27:5869,
113. Roman-Gomez J, Jimenez-Velasco A, Agirre X, et al: Epigenetic regula- 2008.
tion of human cancer/testis antigen gene, HAGE, in chronic myeloid 116. Hambach L, Ling KW, Pool J, et al: Hypomethylating drugs convert
leukemia. Haematologica 92:153, 2007. HA-1-negative solid tumors into targets for stem cell-based immuno-
114. Liu Y, Kuick R, Hanash S, et al: DNA methylation inhibition increases therapy. Blood 113:2715, 2009.
T cell KIR expression through effects on both promoter methylation
and transcription factors. Clin Immunol 130:213, 2009.
